Immunocytochemical Detection of ALK and ROS1 Rearrangements in Lung Cancer Cytological Samples
Author:
Publisher
Springer US
Link
http://link.springer.com/content/pdf/10.1007/978-1-0716-1278-1_12
Reference20 articles.
1. Lindeman NI, Cagle PT, Aisner DL et al (2018) Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. Arch Pathol Lab Med 142:321–346
2. Travis WD, Brambilla E, Nicholson AG et al (2015) The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol 10:1243–1260
3. Shea M, Costa DB, Rangachari D (2016) Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches. Ther Adv Respir Dis 10:113–129
4. Yatabe Y, Dacic S, Borczuk AC et al (2019) Best practices recommendations for diagnostic immunohistochemistry in lung cancer. J Thorac Oncol 14:377–407
5. Pisapia P, Lozano MD, Vigliar E et al (2017) ALK and ROS1 testing on lung cancer cytologic samples: perspectives. Cancer Cytopathol 125:817–830
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cytological Samples: An Asset for the Diagnosis and Therapeutic Management of Patients with Lung Cancer;Cells;2023-02-27
2. Comparison between Immunocytochemistry, FISH and NGS for ALK and ROS1 Rearrangement Detection in Cytological Samples;International Journal of Molecular Sciences;2022-09-12
3. Overview and update on molecular testing in non‐small cell lung carcinoma utilizing endobronchial ultrasound‐guided transbronchial needle aspiration ( EBUS‐TBNA ) samples;Diagnostic Cytopathology;2022-07-28
4. Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications;Genes, Chromosomes and Cancer;2022-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3